Abstract CT135: Cetuximab (C) in patients (Pts) with breast cancer (BC) and non-small cell lung cancer (NSCLC) without reportedKRAS, NRAS, BRAFmutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Fisher, J; Garrett-Mayer, E; Halabi, S; Mangat, PK; Alvarez, RH; Cannon, TL; Crilley, P; Pollock, T; Baghdadi, TA; Cotta, JA; Rygiel, AL; Antonelli, KR; Islam, S; Bruinooge, SS; Schilsky, RL

Published Date

  • July 1, 2019

Published In

  • Clinical Trials

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.am2019-ct135

Conference Name

  • Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA